Reply: MicroRNA-29, a mysterious regulator in myocardial fibrosis and circulating miR-29a as a biomarker

Journal of the American College of Cardiology

Volumn 64, Issue 20, 2014, Pages 2181-2182

  Condorelli, Gianluigi ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA 29; MICRORNA;

CELLS BY BODY ANATOMY; FIBROBLAST; GENE EXPRESSION; GENE SILENCING; GENETIC REGULATION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY CELL; LETTER; MACROPHAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; BLOOD; FEMALE; GENETICS; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTROPHIC CARDIOMYOPATHY; MALE; PATHOLOGY;

BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICRORNAS;

EID: 84922570603     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.04.091     Document Type: Letter

References (1)

1. Roncarati R, Viviani Anselmi C, Losi MA, et al. Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2014;63:920-7.